{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:40:41Z","timestamp":1793256041702,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306225\/2017-4"],"award-info":[{"award-number":["306225\/2017-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/00798-2"],"award-info":[{"award-number":["2013\/00798-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/18747-8"],"award-info":[{"award-number":["2014\/18747-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12964-019-0339-1","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T06:06:02Z","timestamp":1553061962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Recombinant RGD-disintegrin DisBa-01 blocks integrin \u03b1v\u03b23 and impairs VEGF signaling in endothelial cells"],"prefix":"10.1186","volume":"17","author":[{"given":"Ta\u00eds M.","family":"Danilucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty K.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca C.","family":"Pachane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazi\u00e9le F. D.","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael L. B.","family":"Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna C.","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanessa F.","family":"Altei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2372-7814","authenticated-orcid":false,"given":"Heloisa S.","family":"Selistre-de-Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"339_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27\u201331. https:\/\/doi.org\/10.1038\/nm0195-27 .","journal-title":"Nat Med"},{"key":"339_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6:273\u201386. https:\/\/doi.org\/10.1038\/nrd2115 .","journal-title":"Nat Rev Drug Discov"},{"key":"339_CR3","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/nejmra0706596","volume":"358","author":"R Kerbel","year":"2008","unstructured":"Kerbel R. Tumor angiogenesis. N Engl J Med. 2008;358:2039\u201349. https:\/\/doi.org\/10.1056\/nejmra0706596 .","journal-title":"N Engl J Med"},{"key":"339_CR4","doi-asserted-by":"publisher","first-page":"7589","DOI":"10.1073\/pnas.0502935102","volume":"102","author":"S De","year":"2005","unstructured":"De S, Razorenova O, McCabe NP, et al. VEGF-integrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci U S A. 2005;102:7589\u201394. https:\/\/doi.org\/10.1073\/pnas.0502935102 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"339_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669\u201376. https:\/\/doi.org\/10.1038\/nm0603-669 .","journal-title":"Nat Med"},{"key":"339_CR6","doi-asserted-by":"publisher","unstructured":"Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis. 2017;20(2):185\u201304. https:\/\/doi.org\/10.1007\/s10456-017-9552-y .","DOI":"10.1007\/s10456-017-9552-y"},{"key":"339_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12013-008-9040-5","volume":"53","author":"PR Somanath","year":"2009","unstructured":"Somanath PR, Ciocea A, Byzova TV. Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys. 2009;53:53\u201364. https:\/\/doi.org\/10.1007\/s12013-008-9040-5 .","journal-title":"Cell Biochem Biophys"},{"key":"339_CR8","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/febs.12134","volume":"280","author":"AC Rapraeger","year":"2013","unstructured":"Rapraeger AC, Ell BJ, Roy M, et al. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between \u03b1v\u03b23 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis. FEBS J. 2013;280:2194\u2013206. https:\/\/doi.org\/10.1111\/febs.12134 .","journal-title":"FEBS J"},{"key":"339_CR9","doi-asserted-by":"crossref","unstructured":"Zachary I. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem Soc Trans. 2003;31:1171\u20137. https:\/\/doi.org\/10.1042.","DOI":"10.1042\/bst0311171"},{"key":"339_CR10","doi-asserted-by":"publisher","unstructured":"Abhinand CS, Raju R, Soumya SJ, et al. VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal. 2016:1\u20138. https:\/\/doi.org\/10.1007\/s12079-016-0352-8 .","DOI":"10.1007\/s12079-016-0352-8"},{"key":"339_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20150171","volume":"35","author":"GA Smith","year":"2015","unstructured":"Smith GA, Fearnley GW, Tomlinson DC, et al. The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction , trafficking and proteolysis. Biosci Rep. 2015;35:1\u201315. https:\/\/doi.org\/10.1042\/BSR20150171 .","journal-title":"Biosci Rep"},{"key":"339_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0955-0674(03)00096-6","volume":"15","author":"PM Comoglio","year":"2003","unstructured":"Comoglio PM, Boccaccio C, Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol. 2003;15:565\u201371.","journal-title":"Curr Opin Cell Biol"},{"key":"339_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cardiores.2004.04.027","volume":"63","author":"RS Ross","year":"2004","unstructured":"Ross RS. Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors. Cardiovasc Res. 2004;63:381\u201390.","journal-title":"Cardiovasc Res"},{"key":"339_CR14","doi-asserted-by":"publisher","first-page":"e31071","DOI":"10.1371\/journal.pone.0031071","volume":"7","author":"XZ West","year":"2012","unstructured":"West XZ, Meller N, Malinin NL, et al. Integrin b 3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. PLoS One. 2012;7:e31071. https:\/\/doi.org\/10.1371\/journal.pone.0031071 .","journal-title":"PLoS One"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(87)90233-9","volume":"48","author":"RO Hynes","year":"1987","unstructured":"Hynes RO. Integrins: a family of cell surface receptors. Cell. 1987;48:549\u201354.","journal-title":"Cell"},{"key":"339_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nm0902-918","volume":"8","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. A reevaluation of integrins as regulators of angiogenesis. Nat Med. 2002;8:918\u201321. https:\/\/doi.org\/10.1038\/nm0902-918 .","journal-title":"Nat Med"},{"key":"339_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"A-K Olsson","year":"2006","unstructured":"Olsson A-K, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359\u201371. https:\/\/doi.org\/10.1038\/nrm1911 .","journal-title":"Nat Rev Mol Cell Biol"},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/CIRCRESAHA.107.160937","volume":"101","author":"E Brakenhielm","year":"2007","unstructured":"Brakenhielm E. Substrate matters: reciprocally stimulatory integrin and VEGF signaling in endothelial cells. Circ Res. 2007;101:536\u20138. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.160937 .","journal-title":"Circ Res"},{"key":"339_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/emboj\/18.4.882","volume":"18","author":"R Soldi","year":"1999","unstructured":"Soldi R, Mitola S, Strasly M, et al. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 1999;18:882\u201392. https:\/\/doi.org\/10.1093\/emboj\/18.4.882 .","journal-title":"EMBO J"},{"key":"339_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCRESAHA.107.155655","volume":"101","author":"GH Mahabeleshwar","year":"2007","unstructured":"Mahabeleshwar GH, Feng W, Reddy K, et al. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res. 2007;101:570\u201380. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.155655 .","journal-title":"Circ Res"},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4161\/cc.7.3.5234","volume":"7","author":"GH Mahabeleshwar","year":"2008","unstructured":"Mahabeleshwar GH, Chen J, Feng W, et al. Integrin affinity modulation in angiogenesis. Cell Cycle. 2008;7:335\u201347. https:\/\/doi.org\/10.4161\/cc.7.3.5234 .","journal-title":"Cell Cycle"},{"key":"339_CR22","doi-asserted-by":"publisher","unstructured":"West XZ, Meller N, Malinin NL, et al. Integrin\u00a0beta3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. PLoS One. 2012;7. https:\/\/doi.org\/10.1371\/journal.pone.0031071 .","DOI":"10.1371\/journal.pone.0031071"},{"key":"339_CR23","first-page":"293","volume":"149","author":"DR Senger","year":"1996","unstructured":"Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-sergiou A. Stimulation of endothelial cell migration by vascular permeability factor \/ vascular endothelial growth factor through cooperative mechanisms involving the avb3 integrin. Am J Pathol. 1996;149:293\u2013305.","journal-title":"Am J Pathol"},{"key":"339_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1172\/JCI6869","volume":"103","author":"BP Eliceiri","year":"1999","unstructured":"Eliceiri BP, D a C. The role of av integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Dev. 1999;103:1227\u201312330. https:\/\/doi.org\/10.1172\/JCI6869 .","journal-title":"J Clin Dev"},{"key":"339_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1124\/mol.59.5.1333","volume":"59","author":"CH Yeh","year":"2001","unstructured":"Yeh CH, Peng HC, Yang RS, Huang TF. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells. Mol Pharmacol. 2001;59:1333\u201342. https:\/\/doi.org\/10.1124\/mol.59.5.1333 .","journal-title":"Mol Pharmacol"},{"key":"339_CR26","first-page":"3754","volume":"59","author":"IC Kang","year":"1999","unstructured":"Kang IC, Lee YD, Kim DS. A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res. 1999;59:3754\u201360.","journal-title":"Cancer Res"},{"key":"339_CR27","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1073\/pnas.98.4.1853","volume":"98","author":"B Felding-Habermann","year":"2001","unstructured":"Felding-Habermann B, O\u2019Toole TE, Smith JW, et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A. 2001;98:1853\u20138. https:\/\/doi.org\/10.1073\/pnas.98.4.1853 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"339_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000092418","volume":"34","author":"S Swenson","year":"2005","unstructured":"Swenson S, Ernst W, Markland FS. Contortrostatin , a Snake venom Disintegrin with anti-Angiogenic and anti-tumor activity. Pathophysiol Haemost Thromb. 2005;34:169\u201376. https:\/\/doi.org\/10.1159\/000092418 .","journal-title":"Pathophysiol Haemost Thromb"},{"key":"339_CR29","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.2174\/138161207782023793","volume":"13","author":"S Swenson","year":"2007","unstructured":"Swenson S, Ramu S, Markland FS. Anti-angiogenesis and RGD-containing Snake venom Disintegrins. Curr Pharm Des. 2007;13:2860\u201371.","journal-title":"Curr Pharm Des"},{"key":"339_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/mc.22470","volume":"35","author":"O Zakraoui","year":"2016","unstructured":"Zakraoui O, Marcinkiewicz C, Aloui Z, et al. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression. Mol Carcinog. 2016;35:18\u201335 https:\/\/doi.org\/10.1002\/mc.22470 .","journal-title":"Mol Carcinog"},{"key":"339_CR31","doi-asserted-by":"crossref","first-page":"87031","DOI":"10.18632\/oncotarget.13497","volume":"7","author":"Y Tome","year":"2016","unstructured":"Tome Y, Kimura H, Sugimoto N, et al. The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing a \u03bd \u03b2 3 integrin in chick embryo and nude mouse models. Oncotarget. 2016;7:87031\u20136.","journal-title":"Oncotarget"},{"key":"339_CR32","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/toxins2112606","volume":"2","author":"HS Selistre-de-Araujo","year":"2010","unstructured":"Selistre-de-Araujo HS, Pontes CLS, Montenegro CF, Martin ACBM. Snake venom disintegrins and cell migration. Toxins (Basel). 2010;2:2606\u201321.","journal-title":"Toxins (Basel)"},{"key":"339_CR33","first-page":"289","volume":"31","author":"S Niewiarowski","year":"1994","unstructured":"Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol. 1994;31:289\u2013300.","journal-title":"Semin Hematol"},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1021\/bi015627o","volume":"41","author":"JJ Calvete","year":"2002","unstructured":"Calvete JJ, Fox JW, Agelan A, et al. The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on\u00a0\u03b1IIb\u03b23, \u03b1v\u03b23, and\u00a0\u03b15\u03b21 integrins. Biochemistry. 2002;41:2014\u201321. https:\/\/doi.org\/10.1021\/bi015627o .","journal-title":"Biochemistry"},{"key":"339_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10585-007-9101-y","volume":"25","author":"OHP Ramos","year":"2008","unstructured":"Ramos OHP, Kauskot A, Cominetti MR, et al. A novel \u03b1v\u03b23-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis. Clin Exp Metastasis. 2008;25:53\u201364. https:\/\/doi.org\/10.1007\/s10585-007-9101-y .","journal-title":"Clin Exp Metastasis"},{"key":"339_CR36","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.2741\/3176","volume":"13","author":"A Kauskot","year":"2008","unstructured":"Kauskot A, Cominetti MR, Ramos OHP, et al. Hemostatic effects of recombinant DisBa-01, a disintegrin from Bothrops alternatus. Front Biosci. 2008;13:6604\u201316. https:\/\/doi.org\/10.2741\/3176 .","journal-title":"Front Biosci"},{"key":"339_CR37","doi-asserted-by":"publisher","first-page":"e0176226","DOI":"10.1371\/journal.pone.0176226","volume":"12","author":"CF Montenegro","year":"2017","unstructured":"Montenegro CF, Casali BC, Lino RLB, et al. Inhibition of \u03b1v\u03b23 integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC). PLoS One. 2017;12:e0176226. https:\/\/doi.org\/10.1371\/journal.pone.0176226 .","journal-title":"PLoS One"},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.biochi.2012.04.020","volume":"94","author":"CF Montenegro","year":"2012","unstructured":"Montenegro CF, Salla-Pontes CL, Ribeiro JU, et al. Blocking \u03b1v\u03b23 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells. Biochimie. 2012;94:1812\u201320. https:\/\/doi.org\/10.1016\/j.biochi.2012.04.020 .","journal-title":"Biochimie"},{"key":"339_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.toxicon.2014.10.007","volume":"92","author":"P Cassini-Vieira","year":"2014","unstructured":"Cassini-Vieira P, Deconte SR, Tomiosso TC, et al. DisBa-01 inhibits angiogenesis, inflammation and fibrogenesis of sponge-induced-fibrovascular tissue in mice. Toxicon. 2014;92:81\u20139. https:\/\/doi.org\/10.1016\/j.toxicon.2014.10.007 .","journal-title":"Toxicon"},{"key":"339_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and. Methods. 2001;25:402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262 .","journal-title":"Methods"},{"key":"339_CR41","doi-asserted-by":"publisher","unstructured":"Dellinger MT, Brekken RA. Phosphorylation of Akt and ERK1\/2 is required for VEGF-A\/VEGFR2-induced proliferation and migration of lymphatic endothelium. PLoS One. 2011;6. https:\/\/doi.org\/10.1371\/journal.pone.0028947 .","DOI":"10.1371\/journal.pone.0028947"},{"key":"339_CR42","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1073\/pnas.89.11.5192","volume":"89","author":"MD Schaller","year":"1992","unstructured":"Schaller MD, Borgman CA, Cobb BS, et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A. 1992;89:5192\u20136. https:\/\/doi.org\/10.1073\/pnas.89.11.5192 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"339_CR43","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/0140-6736(93)92881-S","volume":"342","author":"TM Weiner","year":"1993","unstructured":"Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene and invasive cancer. Lancet. 1993;342:1024\u20135.","journal-title":"Lancet"},{"key":"339_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10456-009-9141-9","volume":"12","author":"PR Somanath","year":"2009","unstructured":"Somanath PR, Malinin NL, Byzova TV. Cooperation between integrin avB3 and VEGFR2 in angiogenesis. Angiogenesis. 2009;12:177\u201385.","journal-title":"Angiogenesis"},{"key":"339_CR45","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00280-017-3322-9","volume":"79","author":"T Haddad","year":"2017","unstructured":"Haddad T, Qin R, Lupu R, et al. A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2017;79:1221\u20137. https:\/\/doi.org\/10.1007\/s00280-017-3322-9 .","journal-title":"Cancer Chemother Pharmacol"},{"key":"339_CR46","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1470-2045(14)70403-6","volume":"15","author":"OL Chinot","year":"2014","unstructured":"Chinot OL. Cilengitide in glioblastoma: when did it fail? Lancet Oncol. 2014;15:1044\u20135. https:\/\/doi.org\/10.1016\/S1470-2045(14)70403-6 .","journal-title":"Lancet Oncol"},{"key":"339_CR47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.1941","volume":"15","author":"AR Reynolds","year":"2009","unstructured":"Reynolds AR, Hart IR, Watson AR, et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med. 2009;15:392\u2013400. https:\/\/doi.org\/10.1038\/nm.1941 .","journal-title":"Nat Med"},{"key":"339_CR48","doi-asserted-by":"publisher","unstructured":"Alghisi GC, Ponsonnet L, R\u00fcegg C. The integrin antagonist cilengitide activates \u03b1V\u03b23, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One. 2009;4. https:\/\/doi.org\/10.1371\/journal.pone.0004449 .","DOI":"10.1371\/journal.pone.0004449"},{"key":"339_CR49","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood.V92.9.3268","volume":"92","author":"CH Yeh","year":"1998","unstructured":"Yeh CH, Peng HC, Huang TF. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alpha v beta 3 antagonist and inducing apoptosis. Blood. 1998;92:3268\u201376.","journal-title":"Blood"},{"key":"339_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000092418","volume":"34","author":"S Swenson","year":"2006","unstructured":"Swenson S, Costa F, Ernst W, et al. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity. Pathophysiol Haemost Thromb. 2006;34:169\u201376. https:\/\/doi.org\/10.1159\/000092418 .","journal-title":"Pathophysiol Haemost Thromb"},{"key":"339_CR51","doi-asserted-by":"crossref","unstructured":"Wu J, Strawn TL, Luo M, et al. (2015) Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-\u03b1V\u03b23 integrin cross talk. Arterioscler Thromb Vasc Biol 35:111\u2013120. doi: 10.1161\/ATVBAHA.114.304554 10.1111\/j.1600-0854.2006.00462.x","DOI":"10.1161\/ATVBAHA.114.304554"},{"key":"339_CR52","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/j.1600-0854.2006.00462.x","volume":"7","author":"LC Ewan","year":"2006","unstructured":"Ewan LC, Jopling HM, Jia H, et al. Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic. 2006;7:1270\u201382. https:\/\/doi.org\/10.1111\/j.1600-0854.2006.00462.x .","journal-title":"Traffic"},{"key":"339_CR53","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1083\/jcb.200602080","volume":"174","author":"MG Lampugnani","year":"2006","unstructured":"Lampugnani MG, Orsenigo F, Gagliani MC, et al. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol. 2006;174:593\u2013604. https:\/\/doi.org\/10.1083\/jcb.200602080 .","journal-title":"J Cell Biol"},{"key":"339_CR54","first-page":"851","volume":"6","author":"TV Byzova","year":"2000","unstructured":"Byzova TV, Goldman CK, Pampori N, et al. A mechanism for modulation of cellular responses to VEGF\u00a0: activation of the Integrins. Mol Cell. 2000;6:851\u201360.","journal-title":"Mol Cell"},{"key":"339_CR55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4161\/cam.5.2.14403","volume":"5","author":"D Spiering","year":"2011","unstructured":"Spiering D, Hodgson L. Dynamics of the rho-family small GTPases in actin regulation and motility. Cell Adhes Migr. 2011;5:170\u201380.","journal-title":"Cell Adhes Migr"},{"key":"339_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2005.12.021","volume":"9","author":"G Mavria","year":"2006","unstructured":"Mavria G, Vercoulen Y, Yeo M, et al. ERK-MAPK signaling opposes rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell. 2006;9:33\u201344. https:\/\/doi.org\/10.1016\/j.ccr.2005.12.021 .","journal-title":"Cancer Cell"},{"key":"339_CR57","doi-asserted-by":"publisher","unstructured":"Srinivasan R, Zabuawala T, Huang H, et al. Erk1 and erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS One. 2009;4. https:\/\/doi.org\/10.1371\/journal.pone.0008283 .","DOI":"10.1371\/journal.pone.0008283"},{"key":"339_CR58","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1242\/jcs.067009","volume":"124","author":"PP Provenzano","year":"2011","unstructured":"Provenzano PP, Keely PJ. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and rho GTPase signaling. J Cell Sci. 2011;124:1195\u2013205. https:\/\/doi.org\/10.1242\/jcs.067009 .","journal-title":"J Cell Sci"},{"key":"339_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.201307067","volume":"204","author":"C Jean","year":"2014","unstructured":"Jean C, Chen XL, Nam JO, et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J Cell Biol. 2014;204:247\u201363. https:\/\/doi.org\/10.1083\/jcb.201307067 .","journal-title":"J Cell Biol"},{"key":"339_CR60","doi-asserted-by":"publisher","first-page":"8113","DOI":"10.1128\/MCB.24.18.8113","volume":"24","author":"MA Westhoff","year":"2004","unstructured":"Westhoff MA, Serrels B, Fincham VJ, et al. Src-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling Src-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol Cell Biol. 2004;24:8113\u201333. https:\/\/doi.org\/10.1128\/MCB.24.18.8113 .","journal-title":"Mol Cell Biol"},{"key":"339_CR61","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/jcp.25358","volume":"231","author":"E Helal-Neto","year":"2016","unstructured":"Helal-Neto E, Brand\u00e3o-Costa RM, Saldanha-Gama R, et al. Priming endothelial cells with a melanoma-derived extracellular matrix triggers the activation of\u00a0\u03b1v\u03b23\/VEGFR2 Axis. J Cell Physiol. 2016;231:2464\u201373. https:\/\/doi.org\/10.1002\/jcp.25358 .","journal-title":"J Cell Physiol"},{"key":"339_CR62","doi-asserted-by":"publisher","unstructured":"Yang W, Yang Y, Cao J, et al. Paxillin regulates vascular endothelial growth factor A-induced in vitro angiogenesis of human umbilical vein endothelial cells. Mol Med Rep. 2014:1784\u201392. https:\/\/doi.org\/10.3892\/mmr.2014.2961 .","DOI":"10.3892\/mmr.2014.2961"},{"key":"339_CR63","doi-asserted-by":"publisher","unstructured":"Wang J, Yang L, Liang F, et al. Integrin alpha x stimulates cancer angiogenesis through PI3K \/ Akt signaling \u2013 mediated VEGFR2 \/ VEGF - a overexpression in blood vessel endothelial cells. J Cell Biochem. 2018:1807\u201318. https:\/\/doi.org\/10.1002\/jcb.27480 .","DOI":"10.1002\/jcb.27480"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0339-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-019-0339-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0339-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T21:57:10Z","timestamp":1606859830000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-019-0339-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1186\/s12964-019-0339-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"26 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are from the Laboratory of Biochemistry and Molecular Biology, Department of Physiological Sciences, Federal University of S\u00e3o Carlos at S\u00e3o Carlos, S\u00e3o Paulo State, Brazil.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author\u2019s information"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read this manuscript and approved for the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"27"}}